Physician profile
Ashish Bhattacharya
NPI 1467427807
$4,139.06
in general payments reported to CMS, 2019-2025
16 companies · $1,078 in 2025
The $1,078 reported for 2025 was more than what 89% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $193 · 2021: $237 · 2022: $252 · 2023: $615 · 2024: $1,519 · 2025: $1,078.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,916 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,916.49 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $296.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,251.33 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Alloderm, Botox |
| Revance Therapeutics, INC. | $854.73 | 2024-2025 | Daxxify |
| Allergan, INC. | $435.34 | 2019-2022 | |
| Tela Bio, INC. | $282.81 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Acera Surgical, INC. | $248.79 | 2024 | Restrata Wound Matrix |
| Convatec INC. | $234.34 | 2024-2025 | |
| Motiva USA, LLC | $169.64 | 2025 | |
| Sientra, INC. | $165.00 | 2020 | |
| Merz North America, INC. | $144.44 | 2023 | Xeomin |
| Derma Sciences, INC. | $133.30 | 2019 | |
| Baudax Bio INC. | $124.77 | 2022 | |
| Integra Lifesciences Corporation | $42.59 | 2022-2024 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Boston Scientific Corporation | $17.30 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.50 | 2019 | |
| Celgene Corporation | $11.16 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $11.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashish Bhattacharya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.